PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH RECURRENT OR METASTATIC RENAL-CELL CARCINOMA

被引:0
|
作者
ELSON, PJ
WITTE, RS
TRUMP, DL
机构
[1] GUNDERSEN CLIN LTD, LA CROSSE, WI 54601 USA
[2] UNIV WISCONSIN, CTR CLIN CANC, MADISON, WI 53706 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:7310 / 7313
页数:4
相关论文
共 50 条
  • [1] RENAL-CELL CARCINOMA - SURVIVAL AND PROGNOSTIC FACTORS
    GOLIMBU, M
    JOSHI, P
    SPERBER, A
    TESSLER, A
    ALASKARI, S
    MORALES, P
    [J]. UROLOGY, 1986, 27 (04) : 291 - 301
  • [2] Prognostic factors for survival of patients with metastatic renal cell carcinoma
    Ohlmann, C. -H.
    [J]. UROLOGE, 2009, 48 (06): : 625 - 626
  • [3] PROGNOSTIC FACTORS AND SURVIVAL IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA TREATED WITH CHEMOTHERAPY OR INTERFERON-ALPHA
    FOSSA, SD
    KRAMAR, A
    DROZ, JP
    [J]. EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1310 - 1314
  • [4] Conditional survival of patients with metastatic renal-cell carcinoma
    Sun, Maxine
    Quoc-Dien Trinh
    Karakiewicz, Pierre I.
    [J]. LANCET ONCOLOGY, 2012, 13 (11): : E462 - E462
  • [5] What are the prognostic factors for survival in patients with metastatic renal cell carcinoma?
    Brian I Rini
    [J]. Nature Clinical Practice Oncology, 2005, 2 : 292 - 293
  • [6] What are the prognostic factors for survival in patients with metastatic renal cell carcinoma?
    Rini, BI
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06): : 292 - 293
  • [7] PROGNOSTIC FACTORS IN RENAL-CELL CARCINOMA
    EKER, R
    NESLAND, JM
    ANDERSEN, A
    JOHANNESSEN, JV
    [J]. HISTOLOGY AND HISTOPATHOLOGY, 1986, 1 (03) : 255 - 270
  • [8] RENAL-CELL CARCINOMA - PROGNOSTIC FACTORS
    ROOSEN, JU
    ENGEL, U
    JENSEN, RH
    KVIST, E
    SCHOU, G
    [J]. BRITISH JOURNAL OF UROLOGY, 1994, 74 (02): : 160 - 164
  • [9] PROGNOSTIC FACTORS FOR RENAL-CELL CARCINOMA
    MONTIE, JE
    [J]. JOURNAL OF UROLOGY, 1994, 152 (05): : 1397 - 1398
  • [10] A prognostic model for metastatic renal-cell carcinoma
    Galsky, Matthew D.
    [J]. LANCET ONCOLOGY, 2013, 14 (02): : 102 - 103